Biological Therapies or Apremilast in the Treatment of Psoriasis in Patients with a History of Hematologic Malignancy: Results from a Retrospective Study in 21 Patients.

Raphaella Cohen-SorsAnne-Claire FougerousseZiad ReguiaiFrancois MaccariEmmanuel MahéJuliette DelaunayAude RousselMaud Amy de la BretequeCaroline CottencinAntoine BertolottiHélène KempGuillaume Chaby

Published in: Clinical, cosmetic and investigational dermatology (2021)

Despite supportive data regarding tolerance, the heterogeneity of the analyzed population and limited available data, BT and APR should be used with caution in this patient population and investigations on larger cohorts should be conducted to further assess their tolerance in this patient population.

Keyphrases

end stage renal disease
case report
electronic health record
ejection fraction
newly diagnosed
big data
chronic kidney disease
peritoneal dialysis
machine learning
single cell
patient reported outcomes
patient reported